Published in J Mol Biol on October 05, 1992
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J (1994) 3.68
Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med (2000) 1.59
Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. Infect Immun (1999) 1.32
Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. EMBO J (2000) 1.28
Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus. J Struct Biol (2008) 1.27
Ethnic differences of polymorphism of an immunoglobulin VH3 gene. J Clin Invest (1995) 1.27
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses. J Virol (2004) 1.25
A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs (2013) 1.11
Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci U S A (1995) 1.03
Genetic control of DH reading frame and its effect on B-cell development and antigen-specifc antibody production. Crit Rev Immunol (2010) 1.02
Natural and man-made V-gene repertoires for antibody discovery. Front Immunol (2012) 0.98
Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected]. Nat Protoc (2014) 0.96
Antibody binding loop insertions as diversity elements. Nucleic Acids Res (2006) 0.95
Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction. PLoS One (2010) 0.94
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike. Nat Commun (2015) 0.93
Impact of age on hypermutation of immunoglobulin variable genes in humans. J Clin Immunol (2001) 0.92
Single MHC mutation eliminates enthalpy associated with T cell receptor binding. J Mol Biol (2007) 0.90
Sequencing of modern Lepus VDJ genes shows that the usage of VHn genes has been retained in both Oryctolagus and Lepus that diverged 12 million years ago. Immunogenetics (2013) 0.88
The VH gene repertoire of splenic B cells and somatic hypermutation in systemic lupus erythematosus. Arthritis Res Ther (2003) 0.88
Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning. Br J Cancer (2000) 0.88
Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol (2007) 0.87
Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion. Mol Med (2003) 0.87
Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes. Immunology (1995) 0.84
Differential screening of phage-ab libraries by oligonucleotide microarray technology. PLoS One (2008) 0.84
Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies. PLoS One (2015) 0.83
Length-independent structural similarities enrich the antibody CDR canonical class model. MAbs (2016) 0.82
Structural requirements of the major protective antibody to Haemophilus influenzae type b. Infect Immun (1999) 0.82
A complete, multi-level conformational clustering of antibody complementarity-determining regions. PeerJ (2014) 0.81
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform. MAbs (2015) 0.81
Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome. Arthritis Res Ther (2014) 0.81
A highly functional synthetic phage display library containing over 40 billion human antibody clones. PLoS One (2014) 0.80
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody. PLoS One (2012) 0.79
Design and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2). PLoS One (2013) 0.79
Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition. Protein Sci (1995) 0.78
Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody. Retrovirology (2014) 0.78
A very limited number of keywords (main patterns) describes all sequences of the human variable heavy (VH) and kappa (Vkappa) domains. Proc Natl Acad Sci U S A (1997) 0.78
Twenty years of combinatorial antibody libraries, but how well do they mimic the immunoglobulin repertoire? Proc Natl Acad Sci U S A (2009) 0.78
Analysis and modeling of the variable region of camelid single-domain antibodies. J Immunol (2011) 0.78
Disjoint combinations profiling (DCP): a new method for the prediction of antibody CDR conformation from sequence. PeerJ (2014) 0.77
Predicting amino acid sequences of the antibody human VH chains from its first several residues. Proc Natl Acad Sci U S A (1998) 0.77
Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens. Sci Rep (2015) 0.76
Molecular basis for the antagonistic activity of an anti-CXCR4 antibody. MAbs (2016) 0.76
Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient. Immunology (1995) 0.76
Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38. Proc Natl Acad Sci U S A (1994) 0.76
Structural diversity in a human antibody germline library. MAbs (2016) 0.76
Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction. BMC Biotechnol (2015) 0.75
Peptides in headlock - a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy. Sci Rep (2016) 0.75
Determinants of a protein fold. Unique features of the globin amino acid sequences. J Mol Biol (1987) 18.58
The relation between the divergence of sequence and structure in proteins. EMBO J (1986) 16.66
Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 8.67
By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62
Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol (1987) 6.42
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Hydrogen bonding and biological specificity analysed by protein engineering. Nature (1985) 6.20
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
How different amino acid sequences determine similar protein structures: the structure and evolutionary dynamics of the globins. J Mol Biol (1980) 5.85
Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res (1985) 5.57
Interior and surface of monomeric proteins. J Mol Biol (1987) 5.42
Structural mechanisms for domain movements in proteins. Biochemistry (1994) 5.36
Conformations of immunoglobulin hypervariable regions. Nature (1990) 5.31
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature (1989) 5.23
Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype. Nature (1981) 4.86
Reshaping human antibodies for therapy. Nature (1988) 4.82
Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. Nucleic Acids Res (1980) 4.75
The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus). Cell (1984) 4.75
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75
Making antibody fragments using phage display libraries. Nature (1991) 4.61
Airway management for trauma patients with potential cervical spine injuries. Anesth Analg (1991) 4.38
The outline structure of the T-cell alpha beta receptor. EMBO J (1988) 4.37
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 3.99
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res (1991) 3.89
Conditions Affecting Enzyme Synthesis in Cotyledons of Germinating Seeds. Plant Physiol (1960) 3.69
Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J (1994) 3.68
Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev (1993) 3.62
Structure of the neuraminidase gene in human influenza virus A/PR/8/34. Nature (1981) 3.56
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res (2000) 3.55
Standard conformations for the canonical structures of immunoglobulins. J Mol Biol (1997) 3.42
Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci U S A (1985) 3.42
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation (1992) 3.27
The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol (1992) 3.19
Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J Virol (1982) 3.18
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences. Nature (1978) 3.11
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06
Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol (2000) 3.06
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol (1998) 3.05
The binding site for C1q on IgG. Nature (1988) 3.03
"Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A (1993) 2.91
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res (2001) 2.90
Initiation of DNA-dependent RNA synthesis and the effect of heparin on RNA polymerase. Eur J Biochem (1967) 2.87
Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol (1991) 2.80
The accessible surface area and stability of oligomeric proteins. Nature (1987) 2.77
Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding. Nature (1982) 2.63
The human immunoglobulin VH repertoire. Immunol Today (1995) 2.60
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet (1988) 2.51
Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol (1992) 2.50
Evolution of proteins formed by beta-sheets. II. The core of the immunoglobulin domains. J Mol Biol (1982) 2.47
beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors. J Mol Biol (1992) 2.45
Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol (1992) 2.44
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell (1983) 2.42
Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J Virol (1984) 2.41
The use of synthetic oligodeoxynucleotide primers in cloning and sequencing segment of 8 influenza virus (A/PR/8/34). Nucleic Acids Res (1981) 2.40
The structure of the gene encoding the nucleoprotein of human influenza virus A/PR/8/34. Virology (1981) 2.37
Nucleotide sequences of influenza virus segments 1 and 3 reveal mosaic structure of a small viral RNA segment. Cell (1982) 2.33
Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A (1998) 2.32
Site-directed mutagenesis as a probe of enzyme structure and catalysis: tyrosyl-tRNA synthetase cysteine-35 to glycine-35 mutation. Biochemistry (1983) 2.31
Correlation of co-ordinated amino acid substitutions with function in viruses related to tobacco mosaic virus. J Mol Biol (1987) 2.28
Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide. Proc Natl Acad Sci U S A (1982) 2.18
Automation of the collection and processing of X-ray diffraction data -- a generic approach. Acta Crystallogr D Biol Crystallogr (2002) 2.12
The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem (1988) 2.12
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol (1996) 2.08
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Influence of salts on RNA synthesis by DNA-dependent RNA-polymerase from Escherichia coli. Eur J Biochem (1967) 2.06
By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology (N Y) (1992) 2.05
Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol (1997) 2.03
A man who pricked his finger and smelled putrid for 5 years. Lancet (1996) 2.03
Antibodies specific for the polyoma virus middle-size tumor antigen. Proc Natl Acad Sci U S A (1981) 2.02
Psychotropic drugs and preschoolers. Med J Aust (2000) 2.02
Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J (1994) 2.02
A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Res (1998) 2.01
Protein synthesis in Simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1972) 2.01
DNA-binding activity of simian virus 40 large T antigen correlates with a distinct phosphorylation state. J Virol (1984) 2.01
The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase. J Mol Biol (1999) 2.00
Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol (1991) 1.99
Original and artificial antibodies. Nature (1992) 1.97
Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol (1998) 1.96
Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med (1998) 1.95
Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. J Biol Chem (1992) 1.95
Evidence for simian virus 40 (SV40) coding of SV40 T-antigen and the SV40-specific proteins in HeLa cells infected with nondefective adenovirus type 2-SV40 hybrid viruses. J Virol (1977) 1.94
Experience, knowledge and attitudes of mental health staff regarding patients' problematic drug and alcohol use. Aust N Z J Psychiatry (1999) 1.94
Reshaping human antibodies: grafting an antilysozyme activity. Science (1988) 1.92
Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol (2006) 1.92
SH3 domains in prokaryotes. Trends Biochem Sci (1999) 1.91
Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol (1996) 1.90
On the nature of crossreactions observed with antibodies directed to defined epitopes. Proc Natl Acad Sci U S A (1982) 1.89
Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res (1993) 1.87
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotechnol (1997) 1.85
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol (1992) 1.83
Reduced heat resistance of mutant spores after cloning and mutagenesis of the Bacillus subtilis gene encoding penicillin-binding protein 5. J Bacteriol (1986) 1.83